Medical Research and Clinical Trials

AI Breakthrough: UCLA Study Reveals Artificial Intelligence Could Revolutionize Early Detection of "Interval" Breast Cancers

• Medical Research and Clinical Trials

AI Breakthrough: UCLA Study Reveals Artificial Intelligence Could Revolutionize Early Detection of "Interval" Breast Cancers

Ammar Sabilarrohman July 26, 2026

LOS ANGELES, CA – A groundbreaking new study spearheaded by investigators at the UCLA Health Jonsson Comprehensive...

Read More Read more about AI Breakthrough: UCLA Study Reveals Artificial Intelligence Could Revolutionize Early Detection of "Interval" Breast Cancers

Crystalys Therapeutics Secures $130 Million Series B Funding to Advance Gout Therapy Dotinurad Towards Commercialization

• Medical Research and Clinical Trials

Crystalys Therapeutics Secures $130 Million Series B Funding to Advance Gout Therapy Dotinurad Towards Commercialization

Pevita Pearce July 26, 2026

San Francisco, CA – [Insert Date] – Crystalys Therapeutics, a clinical-stage biopharmaceutical company, has successfully closed a...

Read More Read more about Crystalys Therapeutics Secures $130 Million Series B Funding to Advance Gout Therapy Dotinurad Towards Commercialization

AI and Human Collaboration: The Future of Breast Cancer Screening, New Research Suggests

• Medical Research and Clinical Trials

AI and Human Collaboration: The Future of Breast Cancer Screening, New Research Suggests

Dwi Wanna July 26, 2026

URBANA-CHAMPAIGN, IL – The most effective way to leverage the transformative power of artificial intelligence in the...

Read More Read more about AI and Human Collaboration: The Future of Breast Cancer Screening, New Research Suggests

Operation Trialblazer: A Bold Bid to Revitalize US Early-Stage Clinical Research Amidst Global Competition

• Medical Research and Clinical Trials

Operation Trialblazer: A Bold Bid to Revitalize US Early-Stage Clinical Research Amidst Global Competition

Nana Wu July 26, 2026

Washington D.C. – The U.S. Department of Health and Human Services (HHS) has launched "Operation Trialblazer," a...

Read More Read more about Operation Trialblazer: A Bold Bid to Revitalize US Early-Stage Clinical Research Amidst Global Competition

Landmark Cambridge Study Reveals Bilateral Salpingo-Oophorectomy Significantly Reduces Early Death Risk in BRCA1/2 Breast Cancer Patients

• Medical Research and Clinical Trials

Landmark Cambridge Study Reveals Bilateral Salpingo-Oophorectomy Significantly Reduces Early Death Risk in BRCA1/2 Breast Cancer Patients

Azzam Bilal Chamdy July 25, 2026

Cambridge, UK – [Insert Date] – In a groundbreaking study published in The Lancet Oncology, Cambridge researchers...

Read More Read more about Landmark Cambridge Study Reveals Bilateral Salpingo-Oophorectomy Significantly Reduces Early Death Risk in BRCA1/2 Breast Cancer Patients

Bio-Thera Solutions Initiates Phase I Trial for Novel CD25-Targeting Antibody-Drug Conjugate BAT8013 in Advanced Solid Tumors

• Medical Research and Clinical Trials

Bio-Thera Solutions Initiates Phase I Trial for Novel CD25-Targeting Antibody-Drug Conjugate BAT8013 in Advanced Solid Tumors

Asep Darmawan July 25, 2026

A pivotal Phase I clinical trial has commenced, marking a significant step forward in the development of...

Read More Read more about Bio-Thera Solutions Initiates Phase I Trial for Novel CD25-Targeting Antibody-Drug Conjugate BAT8013 in Advanced Solid Tumors

Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

• Medical Research and Clinical Trials

Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

Pevita Pearce July 25, 2026

LA JOLLA, CA – May 12, 2025 – In a landmark study poised to redefine our understanding...

Read More Read more about Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

Johnson & Johnson’s Talvey and Tecvayli Regimens Show Significant Promise in Earlier Multiple Myeloma Treatment Lines

• Medical Research and Clinical Trials

Johnson & Johnson’s Talvey and Tecvayli Regimens Show Significant Promise in Earlier Multiple Myeloma Treatment Lines

Rifan Muazin July 25, 2026

New Phase III data from the MonumenTAL-6 study heralds a potential paradigm shift in multiple myeloma therapy,...

Read More Read more about Johnson & Johnson’s Talvey and Tecvayli Regimens Show Significant Promise in Earlier Multiple Myeloma Treatment Lines

Landmark Patient Recruitment Milestone Achieved for Nizubaglustat in Rare Neurological Disorders

• Medical Research and Clinical Trials

Landmark Patient Recruitment Milestone Achieved for Nizubaglustat in Rare Neurological Disorders

Neng Nana July 25, 2026

Azafaros announces completion of enrollment for pivotal Phase III trial in GM1/GM2 Gangliosidoses, marking a significant stride...

Read More Read more about Landmark Patient Recruitment Milestone Achieved for Nizubaglustat in Rare Neurological Disorders

Cambridge Breakthrough Offers Hope for Aggressive Inherited Breast Cancers: 100% Survival Achieved in Groundbreaking Trial

• Medical Research and Clinical Trials

Cambridge Breakthrough Offers Hope for Aggressive Inherited Breast Cancers: 100% Survival Achieved in Groundbreaking Trial

Asro July 25, 2026

Cambridge, UK – In a development poised to redefine the treatment landscape for aggressive, inherited breast cancers,...

Read More Read more about Cambridge Breakthrough Offers Hope for Aggressive Inherited Breast Cancers: 100% Survival Achieved in Groundbreaking Trial